Our First Transdural Procedure | Neuralink: technical breakdown, key moments and clinical context
Published on 30 June 2026 ('Our First Transdural Procedure | Neuralink', 5:11), this landmark engineering and surgical report documents the first clinical procedure in which the R1 surgical robot inserted the N1 implant's 64 electrode threads straight through the intact dura mater at University Health Network's Toronto Western Hospital—eliminating the manual durotomy (cutting open the dura) and enabling the participant to control a cursor within an hour of surgery.
- Primary record: Official
@neuralinklivestream (F8p2MamNBgE) published on 30 Jun 2026 (duration5:11). - What it shows: First human clinical execution of transdural intracortical thread insertion ('deleting the durotomy').
- Technical pathway: Intact dura mater (>10× thread thickness) → transdural vascular imaging → R1 needle penetration → cortical placement.
- Evidence boundary: First clinical transdural case (30 Jun 2026); long-term multi-patient comparisons remain ongoing.
Watch the official video record
Official upload from @neuralink (30 Jun 2026, 5:11).
Read verbatim official @neuralink YouTube description & caption provenance
Caption & verification basis: English manual + auto-generated captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).
The dura is the brain's armor: a membrane so tough that a surgeon normally cuts through it with a scalpel. For the first time in our clinical trials, we inserted the electrode threads of our implant straight through the dura and into the cortex, keeping the dura intact. This isn't easy. The dura can be over 10x thicker than our electrode threads, which are thinner than a human hair. The brain beneath it is constantly moving, and the membrane hides the very blood vessels we need to avoid. Performing micron-precision insertions under these conditions took extensive engineering work and preclinical study to develop and validate advanced transdural imaging and insertion techniques. We like to say “the best step is no step” and deleting the durectomy takes one of the most delicate manual steps out of the procedure. This potentially means a safer, more repeatable surgery, and a real path to scaling Neuralink to the many people who could benefit. This first-of-its-kind procedure was performed at University Health Network's Toronto Western Hospital as part of our clinical trials. The participant was controlling a cursor with their thoughts within an hour of surgery, and recovery is progressing as expected. Neuralink devices are investigational and have not been approved by the FDA or other regulatory authorities. This video features voluntary clinical trial participants sharing their personal experiences, which may not reflect all participants or future outcomes.
Technical pathway and evidence classification
Intact dura mater (>10× thread thickness) → transdural vascular imaging → R1 needle penetration → cortical placement
First clinical transdural case (30 Jun 2026); long-term multi-patient comparisons remain ongoing.
Timestamped breakdown and key moments
| Timestamp | Segment / event | What happens in the segment |
|---|---|---|
00:00 | Why the dura mater is 'the brain's armor' | Explains why surgeons traditionally cut the dura open and why keeping it intact reduces surgical invasiveness. |
01:30 | Mechanical & optical challenges | Details how the dura is >10× thicker than a thread, moves with brain pulsatility, and obscures underlying blood vessels. |
03:05 | Transdural imaging & needle mechanics | Shows how upgraded R1 optics and laser-milled needles pierce the dura cleanly without buckling. |
04:15 | Toronto Western Hospital clinical outcome | Reports successful clinical implantation with cursor control achieved within one hour post-op. |
What this video demonstrates—and what it does not establish
What this video demonstrates
- First human clinical execution of transdural intracortical thread insertion ('deleting the durotomy').
- International clinical expansion to UHN Toronto Western Hospital (CAN-PRIME).
Scope limits & what it does not establish
- First-of-its-kind clinical milestone; multi-year chronic signal comparison between transdural and durotomy cohorts is still accumulating.
How this fits into Neuralink's broader clinical and hardware roadmap
This video sits inside the N1 hardware & R1 surgical robotics research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at N1 hardware & R1 surgical robotics for cohort context.
Sources checked 30 Oct 2026
Sources and official records
- [1] Neuralink YouTube (2026-06-30): Our First Transdural Procedure | Neuralink ↗ · Verified 30 Oct 2026
- [2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) ↗ · Verified 30 Oct 2026
- [3] Neuralink: Official website and investigational device notice ↗ · Verified 30 Oct 2026
- [4] Neuralink: Approach & Technology (N1 Implant, R1 Robot, Neuralink App) ↗ · Verified 30 Oct 2026
- [5] Neuralink: Official Updates & Engineering Blog ↗ · Verified 30 Oct 2026